McKesson Corporation (MCK) is trading down at $907.99 (-1.45%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.
McKesson Corporation (MCK) Doubles Down on Healthcare Growth With Precision Medicine Acquisition
McKesson Corporation (MCK) Doubles Down on Healthcare Growth With Precision Medicine Acquisition
McKesson to acquire Precision Medicine Group for $2.25bn
McKesson to acquire Precision Medicine Group for $2.25bn
McKesson stock jumps on $2.25B Precision Medicine deal
McKesson stock jumps on $2.25B Precision Medicine deal
McKesson to acquire Precision Medicine Group for $2.25 billion
McKesson to acquire Precision Medicine Group for $2.25 billion
McKesson Buys Precision Medicine to Expand Clinical Research and Commercialization
McKesson Buys Precision Medicine to Expand Clinical Research and Commercialization
McKesson Stock Outlook: Is Wall Street Bullish or Bearish?
McKesson Stock Outlook: Is Wall Street Bullish or Bearish?
McKesson director Bradley Lerman sells $268,589 in shares
McKesson director Bradley Lerman sells $268,589 in shares
McKesson Q1 FY27 slides: 20% EPS growth drives raised outlook
McKesson Q1 FY27 slides: 20% EPS growth drives raised outlook
Earnings call transcript: McKesson tops Q1 2026 estimates and lifts outlook
Earnings call transcript: McKesson tops Q1 2026 estimates and lifts outlook